ADMA Biologics (ADMA) has a market capitalization of $5.2B, based on 238.56M shares at a price of $21.85 (down 1.9% today).
| DATE | CLOSE | VOLUME | OUTSTANDING | MARKET CAP |
|---|---|---|---|---|
April 2025 | $21.86 | 65,587,292 | 238,564,004 | $5,215,009,127.44 |
March 2025 | $19.84 | 76,130,027 | 245,900,700 | $4,878,669,888.00 |
February 2025 | $16.39 | 39,106,123 | 245,900,700 | $4,030,312,473.00 |
January 2025 | $16.15 | 49,950,345 | 245,900,700 | $3,971,296,305.00 |
December 2024 | $17.15 | 52,019,445 | 245,900,700 | $4,217,197,005.00 |
November 2024 | $20.11 | 78,064,818 | 245,900,700 | $4,945,063,077.00 |
October 2024 | $16.31 | 98,981,226 | 245,900,700 | $4,010,640,417.00 |
September 2024 | $19.99 | 147,400,773 | 244,804,100 | $4,893,633,959.00 |
August 2024 | $17.31 | 88,728,124 | 244,804,100 | $4,237,558,971.00 |
July 2024 | $12.28 | 70,658,204 | 244,804,100 | $3,006,194,348.00 |
June 2024 | $11.18 | 65,406,725 | 242,167,100 | $2,707,428,178.00 |
May 2024 | $9.55 | 72,226,388 | 242,167,100 | $2,312,695,805.00 |
April 2024 | $6.52 | 44,981,438 | 242,167,100 | $1,578,929,492.00 |
March 2024 | $6.60 | 66,972,221 | 236,414,400 | $1,560,335,040.00 |
February 2024 | $5.36 | 42,285,956 | 236,414,400 | $1,267,181,184.00 |
January 2024 | $5.19 | 61,179,223 | 236,414,400 | $1,226,990,736.00 |
December 2023 | $4.52 | 36,092,012 | 225,968,400 | $1,021,377,168.00 |
November 2023 | $3.70 | 44,094,314 | 225,968,400 | $836,083,080.00 |
October 2023 | $3.38 | 40,218,146 | 225,968,400 | $763,773,192.00 |
September 2023 | $3.58 | 32,299,244 | 233,761,300 | $836,865,454.00 |
August 2023 | $3.85 | 67,761,738 | 233,761,300 | $899,981,005.00 |
July 2023 | $4.15 | 31,856,746 | 233,761,300 | $970,109,395.00 |
June 2023 | $3.69 | 42,090,965 | 222,683,400 | $821,701,746.00 |
May 2023 | $4.07 | 57,870,533 | 222,683,400 | $906,321,438.00 |
April 2023 | $3.35 | 36,714,408 | 222,683,400 | $745,989,390.00 |
